Trial NCT03912337

View at ClinicalTrials.gov 
Org. Study IDs: 20180060

Last trial update was posted on 2022-07-20

MeSH Interventions

Erenumab

MeSH Conditions

Migraine Disorders

Other Conditions

Migraine

Stopping Reasons

Terminated [Study would not complete enrollment target until 2026 with results available in 2027. The information will not be useful at that time.]

Limitations And Caveats

The study was terminated early due to slow enrollment and the impact of COVID-19 on the work productivity study endpoints, beyond normal operational disruptions.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID